Glenmark gets USFDA nod for chest pain tablets News News / News 6 years ago 511 Views comments Glenmark Pharmaceuticals on Monday said its US arm has received final approval from USFDA for its Nitroglycerin sublingual tablets. Read more
News Arvind Kejriwal and others adversely impacted my reputation: Arun Jaitley News / News - 6 years ago
News Symphony declines 10% on weak Q1 numbers, declared first interim dividend News / News - 6 years ago
News Caustic soda industry doing well; global effects helping: Meghmani Organics News / News - 6 years ago
Comments